A comparison between drug-naïve and treated PD patients.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
A comparison between drug-naïve and treated PD patients.
应用场景：
创建时间：
2018-01-13
相关数据集
Supplementary Material for: Continuous erythropoietin receptor activator for the treatment of chronic dialysis patients with renal anemia in daily clinical practice in Poland: A non-interventional, multi-center, pragmatic NAVIGO trial
Background: Renal anemia is one of the most common complications of chronic kidney disease. This real-life study assessed the effectiveness of methoxy polyethylene glycol-epoetin beta, a continuous er
DataCite Commons2023-10-25 更新100
Orex-A_VAS_Table
Visual-analogue-scale ratings of “right now feeling hungry” and “right now feeling tired” in mm at unaffected rest prior to (pre), 30 (post I) and 90 minutes (post II) following intranasal Orexin A or
DataCite Commons2022-01-03 更新40
Data_Sheet_1_Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test.PDF
Objective: Levodopa up-titration is the primary therapeutic strategy as the Parkinson’s disease (PD) progresses. However, the effects of levodopa up-titration on blood pressure (BP) are inconclusive.
NIAID Data Ecosystem40
Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
CONTEXT AND OBJECTIVES: Assessment of central blood pressure (BP) has grown substantially over recent years because evidence has shown that central BP is more relevant to cardiovascular outcomes than
DataCite Commons2022-06-06 更新90
Desmopressin and bleeding risk in high-risk native kidney biopsy: updated meta-analysis of RCTs and observational studies
Desmopressin (DDAVP) is sometimes used prophylactically to mitigate bleeding complications associated with kidney biopsy in patients with impaired kidney function, although its efficacy remains uncert
Taylor & Francis Group2025-09-01 更新40
